From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
Line 1: |
Line 1: |
- | [[Image:1xzx.gif|left|200px]] | + | {{Seed}} |
| + | [[Image:1xzx.png|left|200px]] |
| | | |
| <!-- | | <!-- |
Line 9: |
Line 10: |
| {{STRUCTURE_1xzx| PDB=1xzx | SCENE= }} | | {{STRUCTURE_1xzx| PDB=1xzx | SCENE= }} |
| | | |
- | '''Thyroxine-Thyroid Hormone Receptor Interactions'''
| + | ===Thyroxine-Thyroid Hormone Receptor Interactions=== |
| | | |
| | | |
- | ==Overview==
| + | <!-- |
- | Thyroid hormone (TH) actions are mediated by nuclear receptors (TRs alpha and beta) that bind triiodothyronine (T(3), 3,5,3'-triiodo-l-thyronine) with high affinity, and its precursor thyroxine (T(4), 3,5,3',5'-tetraiodo-l-thyronine) with lower affinity. T(4) contains a bulky 5' iodine group absent from T(3). Because T(3) is buried in the core of the ligand binding domain (LBD), we have predicted that TH analogues with 5' substituents should fit poorly into the ligand binding pocket and perhaps behave as antagonists. We therefore examined how T(4) affects TR activity and conformation. We obtained several lines of evidence (ligand dissociation kinetics, migration on hydrophobic interaction columns, and non-denaturing gels) that TR-T(4) complexes adopt a conformation that differs from TR-T(3) complexes in solution. Nonetheless, T(4) behaves as an agonist in vitro (in effects on coregulator and DNA binding) and in cells, when conversion to T(3) does not contribute to agonist activity. We determined x-ray crystal structures of the TRbeta LBD in complex with T(3) and T(4) at 2.5-A and 3.1-A resolution. Comparison of the structures reveals that TRbeta accommodates T(4) through subtle alterations in the loop connecting helices 11 and 12 and amino acid side chains in the pocket, which, together, enlarge a niche that permits helix 12 to pack over the 5' iodine and complete the coactivator binding surface. While T(3) is the major active TH, our results suggest that T(4) could activate nuclear TRs at appropriate concentrations. The ability of TR to adapt to the 5' extension should be considered in TR ligand design.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_15466465}}, adds the Publication Abstract to the page |
| + | (as it appears on PubMed at http://www.pubmed.gov), where 15466465 is the PubMed ID number. |
| + | --> |
| + | {{ABSTRACT_PUBMED_15466465}} |
| | | |
| ==About this Structure== | | ==About this Structure== |
Line 34: |
Line 38: |
| [[Category: Webb, P.]] | | [[Category: Webb, P.]] |
| [[Category: Hormone/growth factor receptor]] | | [[Category: Hormone/growth factor receptor]] |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 15:42:47 2008'' | + | |
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 03:57:02 2008'' |
Revision as of 00:57, 29 July 2008
Template:STRUCTURE 1xzx
Thyroxine-Thyroid Hormone Receptor Interactions
Template:ABSTRACT PUBMED 15466465
About this Structure
1XZX is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Thyroxine-thyroid hormone receptor interactions., Sandler B, Webb P, Apriletti JW, Huber BR, Togashi M, Cunha Lima ST, Juric S, Nilsson S, Wagner R, Fletterick RJ, Baxter JD, J Biol Chem. 2004 Dec 31;279(53):55801-8. Epub 2004 Oct 4. PMID:15466465
Page seeded by OCA on Tue Jul 29 03:57:02 2008
Categories: Homo sapiens | Single protein | Apriletti, J W. | Baxter, J D. | Fletterick, R J. | Huber, B R. | Juric, S. | Lima, S T.Cunha. | Nilsson, S. | Sandler, B. | Togashi, M. | Wagner, R. | Webb, P. | Hormone/growth factor receptor